Home Search
drug delivery - search results
If you're not happy with the results, please do another search
How can connected drug delivery devices help patients adhere to their therapies?
Poor adherence to drug therapies can lead to medication waste and poor patient outcomes. Tim Wooller shares some of the reasons behind poor adherence to medication and how connected drug delivery devices can help.
Increasing blood-brain barrier permeability with Acoustic Cluster Therapy (ACT®) to enhance drug delivery in...
Despite the rising incidence of Central Nervous System diseases worldwide, efficient treatment options for neurological disorders remain scarce. Treatment failures are principally associated with the inability of drugs to pass the highly selective Blood-Brain Barrier rather than a lack of efficacy.
Acoustic Cluster Therapy – A novel ultrasound-mediated drug delivery platform for therapeutic enhancement across...
Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.
Polymers and polymer-based drug delivery in the treatment of dry eye disease
Professor Heather Sheardown, C20/20 Ophthalmic Materials Innovation Hub, Department of Chemical Engineering, McMaster University, explores how polymers can be used to treat dry eye disease.
Diabetes monitoring and drug delivery innovation fields: The scenario for big technology synergy
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group provides a market perspective on the diabetes monitoring and drug delivery innovation fields and explains why these are a scenario for big technology synergy
Mathematical Modeling of Drug Delivery via Nanoparticles in Cancer Treatment
Cancer is a complex and heterogeneous disease. Despite all efforts to fight cancer, it continues to impact every segment of society. For example, many patients fail conventional cancer therapies, including chemotherapy, radiation, and surgery; and it is still difficult for physicians to predict a treatment outcome with certainty.
New machine-learning model identifies drug interactions for safer prescribing
Researchers have unveiled a new machine-learning approach to predict drug-accurate interactions.
£5 million fund to combat fatal drug deaths in the UK
In a concerted effort to combat the alarming issue of fatal drug deaths across the UK, the government has allocated £5 million to support 12 groundbreaking projects.
Robotic pill safely delivers injectable Osteoporosis drug
A groundbreaking study demonstrates the efficacy of administering a previously injection-only medication for osteoporosis through an innovative robotic pill.
Healing benefits of honey offers alternative to antimicrobial drugs
According to researchers, the healing benefits of honey are so promising that the sweet substance may replace antimicrobial drugs.
Body posture affects oral drug absorption
Although swallowing a pill is the easiest way of administering a drug, research shows that body posture impacts oral drug absorption.
Ukrainian patients lose access to multiple sclerosis drug trial
Biotechnology giant Roche warns that multiple sclerosis (MS) drug trials are compromised in Ukraine - with patients losing access to crucial treatment.
NHS Digital calls on schools to take part in Smoking, Drinking and Drug Use...
NHS Digital is calling on secondary schools to take part in the Smoking, Drinking and Drug Use among young people in England survey.
COVID-19: Healthcare delivery and digital solutions
Fintan Grant, NHS Digital’s Programme Head for Medicines and Pharmacy charts the recent change in the speed of healthcare delivery in light of COVID-19 including the importance of digital solutions.
A compliance verification package for end-to-end delivery of COVID-19 test kits
Genevieve Leveille, CEO of UK firm 08 Group and Co-Chair of the TechUK DLT Working Group, collaborates with digital health tech companies to deliver verified-safe China-sourced Covid-19 test kits at scale.
Point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond
DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.
Point-of-care devices technology for therapeutic drug monitoring in cancer treatment and beyond
Christian Siebel and Dott.ssa Bianca Posocco detail the work of DIACHEMO, a Euroepan project developing a platform technology for point-of-care devices for chemotherapeutics and other drugs.
Drug development for cancer and inflammatory disease
Sumith A Kularatne, Vice President of Research and Development at On Target Laboratories shares the research strides he has made in drug development
Improving cancer therapy using sonoenhancement with acoustic cluster therapy
Sonoenhancement with Acoustic Cluster Therapy (ACT®) improves drug delivery to solid tumors, and by that reduces the necessary doses and side effects.
Nano DDS technology contributes to next-generation cancer immunotherapy
Dr Takashi Nakamura from Hokkaido University challenges the potential of nano-tech based drug delivery system (Nano DDS) in the development of next-generation cancer immunotherapy.